Delhi | 25°C (windy)

Gilead Taps Veeva Vault CRM for Global Commercial Transformation

  • Nishadil
  • September 11, 2025
  • 0 Comments
  • 1 minutes read
  • 4 Views
Gilead Taps Veeva Vault CRM for Global Commercial Transformation

Veeva Systems (VEEV), a titan in cloud-based software for the life sciences industry, has announced a significant partnership with biopharmaceutical giant Gilead Sciences (GILD). Gilead is set to adopt Veeva Vault CRM for its extensive global commercial operations, marking a pivotal step in the company's digital transformation journey.

This strategic move sees Gilead integrating Veeva Vault CRM across its worldwide commercial teams.

The cloud-based customer relationship management solution is specifically engineered to meet the unique and complex demands of the life sciences sector, offering a comprehensive suite of tools designed to optimize commercial processes and enhance engagement with healthcare professionals.

Veeva Vault CRM is lauded for its ability to unify critical commercial functions on a single, integrated platform.

For Gilead, this translates into a powerful opportunity to streamline global sales and marketing efforts, achieve greater operational efficiencies, and ensure consistent, compliant customer interactions across diverse markets. The platform's advanced capabilities in data management and analytics will empower Gilead's teams with deeper insights, fostering more informed decision-making and ultimately improving patient outcomes through better engagement.

The adoption of Veeva Vault CRM by a company of Gilead's stature underscores Veeva's undisputed leadership in providing innovative and industry-specific technology solutions.

This partnership not only reinforces Veeva's market position but also highlights the ongoing trend within the pharmaceutical and biotech industries to embrace advanced digital tools for greater agility, scalability, and competitive advantage in a rapidly evolving healthcare landscape.

By leveraging Veeva's purpose-built CRM, Gilead aims to elevate its commercial execution, driving more impactful relationships with its stakeholders and ensuring its groundbreaking therapies reach those who need them most, more effectively and efficiently than ever before.

.

Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on